nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—TXN—glaucoma	0.0126	0.126	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00513	0.0515	CbGpPWpGaD
Fludarabine—Adenosine triphosphate—ABCA1—glaucoma	0.00406	1	CrCbGaD
Fludarabine—RRM1—Nucleotide metabolism—TXN—glaucoma	0.00389	0.039	CbGpPWpGaD
Fludarabine—RRM1—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00338	0.0339	CbGpPWpGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00332	0.0333	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00309	0.031	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—TXN—glaucoma	0.00299	0.03	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00289	0.029	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—PEX19—glaucoma	0.0025	0.0251	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00248	0.0248	CbGpPWpGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.00222	0.0222	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00186	0.0187	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00169	0.0169	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.00165	0.0166	CbGpPWpGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.00162	0.0163	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00144	0.0144	CbGpPWpGaD
Fludarabine—RRM1—Fluoropyrimidine Activity—TP53—glaucoma	0.00128	0.0129	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00126	0.0126	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—CDKN2A—glaucoma	0.00122	0.0122	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.00121	0.0121	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—TP53—glaucoma	0.00117	0.0118	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00113	0.0113	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CA5A—glaucoma	0.00112	0.0113	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NARFL—glaucoma	0.00112	0.0113	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—CDKN1B—glaucoma	0.00108	0.0108	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00107	0.0108	CbGpPWpGaD
Fludarabine—Nausea—Carbachol—glaucoma	0.00105	0.00117	CcSEcCtD
Fludarabine—Infection—Travoprost—glaucoma	0.00105	0.00117	CcSEcCtD
Fludarabine—Headache—Methazolamide—glaucoma	0.00105	0.00117	CcSEcCtD
Fludarabine—Arthralgia—Pilocarpine—glaucoma	0.00104	0.00117	CcSEcCtD
Fludarabine—Myalgia—Pilocarpine—glaucoma	0.00104	0.00117	CcSEcCtD
Fludarabine—Paraesthesia—Acetazolamide—glaucoma	0.00104	0.00116	CcSEcCtD
Fludarabine—Nausea—Levobunolol—glaucoma	0.00104	0.00116	CcSEcCtD
Fludarabine—Infection—Brinzolamide—glaucoma	0.00104	0.00116	CcSEcCtD
Fludarabine—Nervous system disorder—Travoprost—glaucoma	0.00104	0.00115	CcSEcCtD
Fludarabine—Discomfort—Pilocarpine—glaucoma	0.00103	0.00115	CcSEcCtD
Fludarabine—Epistaxis—Betaxolol—glaucoma	0.00103	0.00115	CcSEcCtD
Fludarabine—Hyperhidrosis—Dorzolamide—glaucoma	0.00102	0.00114	CcSEcCtD
Fludarabine—Sinusitis—Betaxolol—glaucoma	0.00102	0.00114	CcSEcCtD
Fludarabine—Nervous system disorder—Brinzolamide—glaucoma	0.00102	0.00114	CcSEcCtD
Fludarabine—Rash—Latanoprost—glaucoma	0.00102	0.00114	CcSEcCtD
Fludarabine—Dermatitis—Latanoprost—glaucoma	0.00102	0.00114	CcSEcCtD
Fludarabine—Dyspepsia—Acetazolamide—glaucoma	0.00102	0.00114	CcSEcCtD
Fludarabine—Headache—Latanoprost—glaucoma	0.00101	0.00113	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Brimonidine—glaucoma	0.00101	0.00113	CcSEcCtD
Fludarabine—Anorexia—Dorzolamide—glaucoma	0.00101	0.00113	CcSEcCtD
Fludarabine—Confusional state—Pilocarpine—glaucoma	0.00101	0.00113	CcSEcCtD
Fludarabine—Arrhythmia—Clonidine—glaucoma	0.00101	0.00112	CcSEcCtD
Fludarabine—Decreased appetite—Acetazolamide—glaucoma	0.00101	0.00112	CcSEcCtD
Fludarabine—Oedema—Pilocarpine—glaucoma	0.001	0.00112	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000998	0.00111	CcSEcCtD
Fludarabine—Fatigue—Acetazolamide—glaucoma	0.000997	0.00111	CcSEcCtD
Fludarabine—Paraesthesia—Brimonidine—glaucoma	0.000997	0.00111	CcSEcCtD
Fludarabine—Infection—Pilocarpine—glaucoma	0.000995	0.00111	CcSEcCtD
Fludarabine—Alopecia—Clonidine—glaucoma	0.000995	0.00111	CcSEcCtD
Fludarabine—Nausea—Methazolamide—glaucoma	0.000992	0.00111	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.00099	0.00992	CbGpPWpGaD
Fludarabine—Dyspnoea—Brimonidine—glaucoma	0.00099	0.0011	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000983	0.00986	CbGpPWpGaD
Fludarabine—Thrombocytopenia—Pilocarpine—glaucoma	0.000981	0.00109	CcSEcCtD
Fludarabine—Dyspepsia—Brimonidine—glaucoma	0.000977	0.00109	CcSEcCtD
Fludarabine—Hypoaesthesia—Betaxolol—glaucoma	0.000975	0.00109	CcSEcCtD
Fludarabine—Angina pectoris—Timolol—glaucoma	0.000974	0.00109	CcSEcCtD
Fludarabine—Pharyngitis—Betaxolol—glaucoma	0.000973	0.00109	CcSEcCtD
Fludarabine—Hyperhidrosis—Pilocarpine—glaucoma	0.000968	0.00108	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000966	0.00108	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Travoprost—glaucoma	0.000962	0.00107	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000958	0.00107	CcSEcCtD
Fludarabine—Fatigue—Brimonidine—glaucoma	0.000957	0.00107	CcSEcCtD
Fludarabine—Anorexia—Pilocarpine—glaucoma	0.000955	0.00107	CcSEcCtD
Fludarabine—Feeling abnormal—Acetazolamide—glaucoma	0.000953	0.00106	CcSEcCtD
Fludarabine—Hypersensitivity—Apraclonidine—glaucoma	0.000953	0.00106	CcSEcCtD
Fludarabine—Paraesthesia—Dorzolamide—glaucoma	0.000952	0.00106	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000949	0.00106	CcSEcCtD
Fludarabine—Pain—Brimonidine—glaucoma	0.000949	0.00106	CcSEcCtD
Fludarabine—Dyspnoea—Dorzolamide—glaucoma	0.000945	0.00105	CcSEcCtD
Fludarabine—Visual impairment—Betaxolol—glaucoma	0.000945	0.00105	CcSEcCtD
Fludarabine—Dyspnoea—Travoprost—glaucoma	0.000941	0.00105	CcSEcCtD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.00094	0.00943	CbGpPWpGaD
Fludarabine—Paraesthesia—Brinzolamide—glaucoma	0.000936	0.00104	CcSEcCtD
Fludarabine—Dysuria—Timolol—glaucoma	0.000935	0.00104	CcSEcCtD
Fludarabine—Dyspepsia—Dorzolamide—glaucoma	0.000933	0.00104	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Timolol—glaucoma	0.00093	0.00104	CcSEcCtD
Fludarabine—Dyspnoea—Brinzolamide—glaucoma	0.000929	0.00104	CcSEcCtD
Fludarabine—Dyspepsia—Travoprost—glaucoma	0.000929	0.00104	CcSEcCtD
Fludarabine—Asthenia—Apraclonidine—glaucoma	0.000928	0.00104	CcSEcCtD
Fludarabine—Decreased appetite—Dorzolamide—glaucoma	0.000921	0.00103	CcSEcCtD
Fludarabine—Dyspepsia—Brinzolamide—glaucoma	0.000917	0.00102	CcSEcCtD
Fludarabine—Pruritus—Apraclonidine—glaucoma	0.000915	0.00102	CcSEcCtD
Fludarabine—Body temperature increased—Acetazolamide—glaucoma	0.000914	0.00102	CcSEcCtD
Fludarabine—Fatigue—Dorzolamide—glaucoma	0.000914	0.00102	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000913	0.00102	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Travoprost—glaucoma	0.000911	0.00102	CcSEcCtD
Fludarabine—Fatigue—Travoprost—glaucoma	0.00091	0.00102	CcSEcCtD
Fludarabine—Ill-defined disorder—Clonidine—glaucoma	0.000909	0.00101	CcSEcCtD
Fludarabine—Pain—Dorzolamide—glaucoma	0.000906	0.00101	CcSEcCtD
Fludarabine—Decreased appetite—Brinzolamide—glaucoma	0.000906	0.00101	CcSEcCtD
Fludarabine—Pain—Travoprost—glaucoma	0.000903	0.00101	CcSEcCtD
Fludarabine—Constipation—Travoprost—glaucoma	0.000903	0.00101	CcSEcCtD
Fludarabine—Hyperglycaemia—Timolol—glaucoma	0.000902	0.00101	CcSEcCtD
Fludarabine—Agitation—Clonidine—glaucoma	0.000901	0.001	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.0009	0.001	CcSEcCtD
Fludarabine—Paraesthesia—Pilocarpine—glaucoma	0.000899	0.001	CcSEcCtD
Fludarabine—Asthenia—Bimatoprost—glaucoma	0.000899	0.001	CcSEcCtD
Fludarabine—Fatigue—Brinzolamide—glaucoma	0.000898	0.001	CcSEcCtD
Fludarabine—Dyspnoea—Pilocarpine—glaucoma	0.000893	0.000996	CcSEcCtD
Fludarabine—Pain—Brinzolamide—glaucoma	0.000891	0.000994	CcSEcCtD
Fludarabine—Pruritus—Bimatoprost—glaucoma	0.000887	0.00099	CcSEcCtD
Fludarabine—Diarrhoea—Apraclonidine—glaucoma	0.000885	0.000987	CcSEcCtD
Fludarabine—Malaise—Clonidine—glaucoma	0.000884	0.000986	CcSEcCtD
Fludarabine—Dyspepsia—Pilocarpine—glaucoma	0.000882	0.000984	CcSEcCtD
Fludarabine—Chills—Betaxolol—glaucoma	0.000879	0.000981	CcSEcCtD
Fludarabine—Arrhythmia—Betaxolol—glaucoma	0.000876	0.000977	CcSEcCtD
Fludarabine—Feeling abnormal—Dorzolamide—glaucoma	0.000873	0.000975	CcSEcCtD
Fludarabine—Decreased appetite—Pilocarpine—glaucoma	0.000871	0.000972	CcSEcCtD
Fludarabine—Feeling abnormal—Travoprost—glaucoma	0.00087	0.00097	CcSEcCtD
Fludarabine—Alopecia—Betaxolol—glaucoma	0.000866	0.000966	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000865	0.000965	CcSEcCtD
Fludarabine—DCK—Metabolism—CA5A—glaucoma	0.000864	0.00866	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NARFL—glaucoma	0.000864	0.00866	CbGpPWpGaD
Fludarabine—Feeling abnormal—Brinzolamide—glaucoma	0.000859	0.000958	CcSEcCtD
Fludarabine—Pain—Pilocarpine—glaucoma	0.000857	0.000956	CcSEcCtD
Fludarabine—Constipation—Pilocarpine—glaucoma	0.000857	0.000956	CcSEcCtD
Fludarabine—Cough—Clonidine—glaucoma	0.000855	0.000954	CcSEcCtD
Fludarabine—Malnutrition—Betaxolol—glaucoma	0.000853	0.000952	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000841	0.00844	CbGpPWpGaD
Fludarabine—Epistaxis—Timolol—glaucoma	0.000841	0.000939	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00084	0.00843	CbGpPWpGaD
Fludarabine—Body temperature increased—Dorzolamide—glaucoma	0.000838	0.000935	CcSEcCtD
Fludarabine—Sinusitis—Timolol—glaucoma	0.000837	0.000934	CcSEcCtD
Fludarabine—Arthralgia—Clonidine—glaucoma	0.000834	0.000931	CcSEcCtD
Fludarabine—Asthenia—Acetazolamide—glaucoma	0.00083	0.000926	CcSEcCtD
Fludarabine—Feeling abnormal—Pilocarpine—glaucoma	0.000825	0.000921	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000825	0.00827	CbGpPWpGaD
Fludarabine—Discomfort—Clonidine—glaucoma	0.000824	0.00092	CcSEcCtD
Fludarabine—Vomiting—Apraclonidine—glaucoma	0.000822	0.000917	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCND2—glaucoma	0.000821	0.00823	CbGpPWpGaD
Fludarabine—Hypersensitivity—Brimonidine—glaucoma	0.000818	0.000912	CcSEcCtD
Fludarabine—Dermatitis—Apraclonidine—glaucoma	0.000814	0.000909	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000811	0.00813	CbGpPWpGaD
Fludarabine—Headache—Apraclonidine—glaucoma	0.00081	0.000904	CcSEcCtD
Fludarabine—Confusional state—Clonidine—glaucoma	0.000807	0.0009	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000804	0.00806	CbGpPWpGaD
Fludarabine—Oedema—Clonidine—glaucoma	0.0008	0.000893	CcSEcCtD
Fludarabine—Asthenia—Brimonidine—glaucoma	0.000796	0.000889	CcSEcCtD
Fludarabine—Infection—Clonidine—glaucoma	0.000795	0.000887	CcSEcCtD
Fludarabine—Body temperature increased—Pilocarpine—glaucoma	0.000792	0.000884	CcSEcCtD
Fludarabine—Ill-defined disorder—Betaxolol—glaucoma	0.000792	0.000883	CcSEcCtD
Fludarabine—Diarrhoea—Acetazolamide—glaucoma	0.000791	0.000883	CcSEcCtD
Fludarabine—Rash—Bimatoprost—glaucoma	0.00079	0.000882	CcSEcCtD
Fludarabine—Dermatitis—Bimatoprost—glaucoma	0.00079	0.000881	CcSEcCtD
Fludarabine—Anaemia—Betaxolol—glaucoma	0.000789	0.00088	CcSEcCtD
Fludarabine—Pruritus—Brimonidine—glaucoma	0.000785	0.000876	CcSEcCtD
Fludarabine—Headache—Bimatoprost—glaucoma	0.000785	0.000876	CcSEcCtD
Fludarabine—Nervous system disorder—Clonidine—glaucoma	0.000784	0.000875	CcSEcCtD
Fludarabine—Thrombocytopenia—Clonidine—glaucoma	0.000783	0.000874	CcSEcCtD
Fludarabine—Hypersensitivity—Dorzolamide—glaucoma	0.000781	0.000871	CcSEcCtD
Fludarabine—Hypersensitivity—Travoprost—glaucoma	0.000778	0.000868	CcSEcCtD
Fludarabine—Hyperhidrosis—Clonidine—glaucoma	0.000773	0.000863	CcSEcCtD
Fludarabine—Visual impairment—Timolol—glaucoma	0.000772	0.000861	CcSEcCtD
Fludarabine—Malaise—Betaxolol—glaucoma	0.000769	0.000859	CcSEcCtD
Fludarabine—Nausea—Apraclonidine—glaucoma	0.000768	0.000857	CcSEcCtD
Fludarabine—Hypersensitivity—Brinzolamide—glaucoma	0.000768	0.000857	CcSEcCtD
Fludarabine—Anorexia—Clonidine—glaucoma	0.000762	0.000851	CcSEcCtD
Fludarabine—Asthenia—Dorzolamide—glaucoma	0.000761	0.000849	CcSEcCtD
Fludarabine—Asthenia—Travoprost—glaucoma	0.000757	0.000845	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000756	0.00758	CbGpPWpGaD
Fludarabine—Pruritus—Dorzolamide—glaucoma	0.00075	0.000837	CcSEcCtD
Fludarabine—Asthenia—Brinzolamide—glaucoma	0.000748	0.000834	CcSEcCtD
Fludarabine—Pruritus—Travoprost—glaucoma	0.000747	0.000833	CcSEcCtD
Fludarabine—Cough—Betaxolol—glaucoma	0.000745	0.000831	CcSEcCtD
Fludarabine—Nausea—Bimatoprost—glaucoma	0.000745	0.000831	CcSEcCtD
Fludarabine—Hypersensitivity—Pilocarpine—glaucoma	0.000738	0.000823	CcSEcCtD
Fludarabine—Pruritus—Brinzolamide—glaucoma	0.000737	0.000823	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000736	0.00738	CbGpPWpGaD
Fludarabine—Vomiting—Acetazolamide—glaucoma	0.000735	0.00082	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000729	0.000813	CcSEcCtD
Fludarabine—Myalgia—Betaxolol—glaucoma	0.000726	0.000811	CcSEcCtD
Fludarabine—Arthralgia—Betaxolol—glaucoma	0.000726	0.000811	CcSEcCtD
Fludarabine—Diarrhoea—Dorzolamide—glaucoma	0.000725	0.000809	CcSEcCtD
Fludarabine—Headache—Acetazolamide—glaucoma	0.000724	0.000808	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000723	0.00725	CbGpPWpGaD
Fludarabine—Diarrhoea—Travoprost—glaucoma	0.000722	0.000806	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.00072	0.00721	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—FGFR1OP—glaucoma	0.000719	0.00721	CbGpPWpGaD
Fludarabine—Asthenia—Pilocarpine—glaucoma	0.000719	0.000802	CcSEcCtD
Fludarabine—Paraesthesia—Clonidine—glaucoma	0.000718	0.000801	CcSEcCtD
Fludarabine—Discomfort—Betaxolol—glaucoma	0.000718	0.000801	CcSEcCtD
Fludarabine—Arrhythmia—Timolol—glaucoma	0.000715	0.000798	CcSEcCtD
Fludarabine—Dyspnoea—Clonidine—glaucoma	0.000713	0.000796	CcSEcCtD
Fludarabine—Diarrhoea—Brinzolamide—glaucoma	0.000713	0.000796	CcSEcCtD
Fludarabine—Pruritus—Pilocarpine—glaucoma	0.000709	0.000791	CcSEcCtD
Fludarabine—Alopecia—Timolol—glaucoma	0.000708	0.00079	CcSEcCtD
Fludarabine—Confusional state—Betaxolol—glaucoma	0.000702	0.000783	CcSEcCtD
Fludarabine—Rash—Brimonidine—glaucoma	0.0007	0.000781	CcSEcCtD
Fludarabine—Dermatitis—Brimonidine—glaucoma	0.000699	0.00078	CcSEcCtD
Fludarabine—Malnutrition—Timolol—glaucoma	0.000697	0.000778	CcSEcCtD
Fludarabine—Oedema—Betaxolol—glaucoma	0.000696	0.000777	CcSEcCtD
Fludarabine—Headache—Brimonidine—glaucoma	0.000695	0.000776	CcSEcCtD
Fludarabine—Decreased appetite—Clonidine—glaucoma	0.000695	0.000776	CcSEcCtD
Fludarabine—Infection—Betaxolol—glaucoma	0.000692	0.000772	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Clonidine—glaucoma	0.000691	0.000771	CcSEcCtD
Fludarabine—Fatigue—Clonidine—glaucoma	0.00069	0.000769	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—CDKN2A—glaucoma	0.000688	0.0069	CbGpPWpGaD
Fludarabine—Nausea—Acetazolamide—glaucoma	0.000687	0.000766	CcSEcCtD
Fludarabine—Diarrhoea—Pilocarpine—glaucoma	0.000685	0.000765	CcSEcCtD
Fludarabine—Pain—Clonidine—glaucoma	0.000684	0.000763	CcSEcCtD
Fludarabine—Constipation—Clonidine—glaucoma	0.000684	0.000763	CcSEcCtD
Fludarabine—Nervous system disorder—Betaxolol—glaucoma	0.000683	0.000762	CcSEcCtD
Fludarabine—Thrombocytopenia—Betaxolol—glaucoma	0.000682	0.000761	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—RAB8A—glaucoma	0.000676	0.00678	CbGpPWpGaD
Fludarabine—Vomiting—Dorzolamide—glaucoma	0.000674	0.000752	CcSEcCtD
Fludarabine—Hyperhidrosis—Betaxolol—glaucoma	0.000673	0.000751	CcSEcCtD
Fludarabine—Rash—Dorzolamide—glaucoma	0.000668	0.000746	CcSEcCtD
Fludarabine—Dermatitis—Dorzolamide—glaucoma	0.000668	0.000745	CcSEcCtD
Fludarabine—Rash—Travoprost—glaucoma	0.000665	0.000743	CcSEcCtD
Fludarabine—Dermatitis—Travoprost—glaucoma	0.000665	0.000742	CcSEcCtD
Fludarabine—Headache—Dorzolamide—glaucoma	0.000664	0.000741	CcSEcCtD
Fludarabine—Anorexia—Betaxolol—glaucoma	0.000664	0.000741	CcSEcCtD
Fludarabine—Vomiting—Brinzolamide—glaucoma	0.000663	0.000739	CcSEcCtD
Fludarabine—Headache—Travoprost—glaucoma	0.000661	0.000738	CcSEcCtD
Fludarabine—Nausea—Brimonidine—glaucoma	0.000659	0.000736	CcSEcCtD
Fludarabine—Feeling abnormal—Clonidine—glaucoma	0.000659	0.000735	CcSEcCtD
Fludarabine—Rash—Brinzolamide—glaucoma	0.000657	0.000733	CcSEcCtD
Fludarabine—Dermatitis—Brinzolamide—glaucoma	0.000656	0.000733	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—OPTN—glaucoma	0.000656	0.00657	CbGpPWpGaD
Fludarabine—Headache—Brinzolamide—glaucoma	0.000653	0.000728	CcSEcCtD
Fludarabine—Vomiting—Pilocarpine—glaucoma	0.000637	0.000711	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000634	0.000708	CcSEcCtD
Fludarabine—Body temperature increased—Clonidine—glaucoma	0.000632	0.000706	CcSEcCtD
Fludarabine—Rash—Pilocarpine—glaucoma	0.000632	0.000705	CcSEcCtD
Fludarabine—Dermatitis—Pilocarpine—glaucoma	0.000631	0.000704	CcSEcCtD
Fludarabine—Nausea—Dorzolamide—glaucoma	0.00063	0.000703	CcSEcCtD
Fludarabine—Headache—Pilocarpine—glaucoma	0.000627	0.0007	CcSEcCtD
Fludarabine—Nausea—Travoprost—glaucoma	0.000627	0.0007	CcSEcCtD
Fludarabine—Paraesthesia—Betaxolol—glaucoma	0.000625	0.000698	CcSEcCtD
Fludarabine—Dyspnoea—Betaxolol—glaucoma	0.000621	0.000693	CcSEcCtD
Fludarabine—Nausea—Brinzolamide—glaucoma	0.000619	0.000691	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000615	0.00617	CbGpPWpGaD
Fludarabine—Dyspepsia—Betaxolol—glaucoma	0.000613	0.000684	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—CDKN1B—glaucoma	0.000609	0.00611	CbGpPWpGaD
Fludarabine—Cough—Timolol—glaucoma	0.000608	0.000679	CcSEcCtD
Fludarabine—Decreased appetite—Betaxolol—glaucoma	0.000605	0.000675	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000605	0.00606	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000601	0.000671	CcSEcCtD
Fludarabine—Fatigue—Betaxolol—glaucoma	0.0006	0.00067	CcSEcCtD
Fludarabine—Pain—Betaxolol—glaucoma	0.000595	0.000664	CcSEcCtD
Fludarabine—Constipation—Betaxolol—glaucoma	0.000595	0.000664	CcSEcCtD
Fludarabine—Nausea—Pilocarpine—glaucoma	0.000595	0.000664	CcSEcCtD
Fludarabine—Myalgia—Timolol—glaucoma	0.000593	0.000662	CcSEcCtD
Fludarabine—Arthralgia—Timolol—glaucoma	0.000593	0.000662	CcSEcCtD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000591	0.00592	CbGpPWpGaD
Fludarabine—Hypersensitivity—Clonidine—glaucoma	0.000589	0.000658	CcSEcCtD
Fludarabine—Discomfort—Timolol—glaucoma	0.000586	0.000654	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—OPTN—glaucoma	0.000586	0.00588	CbGpPWpGaD
Fludarabine—Asthenia—Clonidine—glaucoma	0.000574	0.00064	CcSEcCtD
Fludarabine—Feeling abnormal—Betaxolol—glaucoma	0.000574	0.00064	CcSEcCtD
Fludarabine—Confusional state—Timolol—glaucoma	0.000574	0.00064	CcSEcCtD
Fludarabine—Anaphylactic shock—Timolol—glaucoma	0.000569	0.000635	CcSEcCtD
Fludarabine—Oedema—Timolol—glaucoma	0.000569	0.000635	CcSEcCtD
Fludarabine—Pruritus—Clonidine—glaucoma	0.000566	0.000631	CcSEcCtD
Fludarabine—Infection—Timolol—glaucoma	0.000565	0.000631	CcSEcCtD
Fludarabine—Nervous system disorder—Timolol—glaucoma	0.000558	0.000623	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000557	0.00559	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000554	0.00555	CbGpPWpGaD
Fludarabine—Body temperature increased—Betaxolol—glaucoma	0.00055	0.000614	CcSEcCtD
Fludarabine—Hyperhidrosis—Timolol—glaucoma	0.00055	0.000614	CcSEcCtD
Fludarabine—RRM1—Metabolism—CA1—glaucoma	0.000548	0.0055	CbGpPWpGaD
Fludarabine—Diarrhoea—Clonidine—glaucoma	0.000547	0.000611	CcSEcCtD
Fludarabine—Anorexia—Timolol—glaucoma	0.000542	0.000605	CcSEcCtD
Fludarabine—RRM1—Metabolism—CTSA—glaucoma	0.000531	0.00533	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.00053	0.00531	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000529	0.0053	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Timolol—glaucoma	0.000518	0.000578	CcSEcCtD
Fludarabine—Hypersensitivity—Betaxolol—glaucoma	0.000513	0.000572	CcSEcCtD
Fludarabine—Paraesthesia—Timolol—glaucoma	0.000511	0.00057	CcSEcCtD
Fludarabine—Vomiting—Clonidine—glaucoma	0.000509	0.000567	CcSEcCtD
Fludarabine—Dyspnoea—Timolol—glaucoma	0.000507	0.000566	CcSEcCtD
Fludarabine—Rash—Clonidine—glaucoma	0.000504	0.000563	CcSEcCtD
Fludarabine—Dermatitis—Clonidine—glaucoma	0.000504	0.000562	CcSEcCtD
Fludarabine—RRM1—Metabolism—CA2—glaucoma	0.000502	0.00503	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000501	0.00502	CbGpPWpGaD
Fludarabine—Headache—Clonidine—glaucoma	0.000501	0.000559	CcSEcCtD
Fludarabine—Dyspepsia—Timolol—glaucoma	0.000501	0.000559	CcSEcCtD
Fludarabine—Asthenia—Betaxolol—glaucoma	0.0005	0.000558	CcSEcCtD
Fludarabine—Decreased appetite—Timolol—glaucoma	0.000495	0.000552	CcSEcCtD
Fludarabine—Pruritus—Betaxolol—glaucoma	0.000493	0.00055	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Timolol—glaucoma	0.000491	0.000548	CcSEcCtD
Fludarabine—Fatigue—Timolol—glaucoma	0.00049	0.000547	CcSEcCtD
Fludarabine—POLA1—Synthesis of DNA—CDKN1B—glaucoma	0.000489	0.00491	CbGpPWpGaD
Fludarabine—Pain—Timolol—glaucoma	0.000486	0.000543	CcSEcCtD
Fludarabine—Diarrhoea—Betaxolol—glaucoma	0.000476	0.000532	CcSEcCtD
Fludarabine—Nausea—Clonidine—glaucoma	0.000475	0.00053	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000474	0.00475	CbGpPWpGaD
Fludarabine—Feeling abnormal—Timolol—glaucoma	0.000469	0.000523	CcSEcCtD
Fludarabine—POLA1—DNA Replication—CDKN1B—glaucoma	0.000459	0.0046	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000455	0.00456	CbGpPWpGaD
Fludarabine—Body temperature increased—Timolol—glaucoma	0.00045	0.000502	CcSEcCtD
Fludarabine—Vomiting—Betaxolol—glaucoma	0.000443	0.000494	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—CDKN1B—glaucoma	0.000442	0.00443	CbGpPWpGaD
Fludarabine—Rash—Betaxolol—glaucoma	0.000439	0.00049	CcSEcCtD
Fludarabine—Dermatitis—Betaxolol—glaucoma	0.000439	0.000489	CcSEcCtD
Fludarabine—Headache—Betaxolol—glaucoma	0.000436	0.000487	CcSEcCtD
Fludarabine—DCK—Metabolism—CA1—glaucoma	0.000422	0.00423	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000421	0.00422	CbGpPWpGaD
Fludarabine—Hypersensitivity—Timolol—glaucoma	0.000419	0.000468	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000417	0.00418	CbGpPWpGaD
Fludarabine—Nausea—Betaxolol—glaucoma	0.000414	0.000462	CcSEcCtD
Fludarabine—DCK—Metabolism—CTSA—glaucoma	0.000409	0.0041	CbGpPWpGaD
Fludarabine—Asthenia—Timolol—glaucoma	0.000408	0.000455	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000405	0.00406	CbGpPWpGaD
Fludarabine—Pruritus—Timolol—glaucoma	0.000402	0.000449	CcSEcCtD
Fludarabine—POLA1—S Phase—CDKN1B—glaucoma	0.000401	0.00402	CbGpPWpGaD
Fludarabine—Diarrhoea—Timolol—glaucoma	0.000389	0.000434	CcSEcCtD
Fludarabine—DCK—Metabolism—CA2—glaucoma	0.000386	0.00387	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000373	0.00374	CbGpPWpGaD
Fludarabine—Vomiting—Timolol—glaucoma	0.000362	0.000404	CcSEcCtD
Fludarabine—Rash—Timolol—glaucoma	0.000359	0.0004	CcSEcCtD
Fludarabine—Dermatitis—Timolol—glaucoma	0.000358	0.0004	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000357	0.00358	CbGpPWpGaD
Fludarabine—Headache—Timolol—glaucoma	0.000356	0.000398	CcSEcCtD
Fludarabine—RRM1—Metabolism—TXN—glaucoma	0.000353	0.00354	CbGpPWpGaD
Fludarabine—Nausea—Timolol—glaucoma	0.000338	0.000377	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000333	0.00334	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000315	0.00316	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND2—glaucoma	0.000301	0.00302	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000298	0.00299	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000282	0.00283	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTT1—glaucoma	0.000274	0.00275	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TXN—glaucoma	0.000272	0.00273	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.00027	0.00271	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND2—glaucoma	0.000269	0.0027	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN2B—glaucoma	0.000241	0.00242	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000235	0.00235	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCA1—glaucoma	0.000218	0.00219	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP1B1—glaucoma	0.000218	0.00219	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTT1—glaucoma	0.000211	0.00211	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000201	0.00202	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000177	0.00178	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTM1—glaucoma	0.000175	0.00175	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCA1—glaucoma	0.000168	0.00168	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP1B1—glaucoma	0.000168	0.00168	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000154	0.00155	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTHFR—glaucoma	0.000154	0.00155	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOE—glaucoma	0.000144	0.00144	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CAV1—glaucoma	0.000142	0.00143	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN2A—glaucoma	0.000138	0.00138	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000137	0.00137	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTM1—glaucoma	0.000134	0.00135	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN1B—glaucoma	0.000122	0.00123	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTHFR—glaucoma	0.000119	0.00119	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOE—glaucoma	0.000111	0.00111	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CAV1—glaucoma	0.00011	0.0011	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NOS3—glaucoma	0.000108	0.00108	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGS2—glaucoma	9.84e-05	0.000987	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NOS3—glaucoma	8.28e-05	0.00083	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—glaucoma	7.68e-05	0.00077	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS2—glaucoma	7.57e-05	0.000759	CbGpPWpGaD
